Martin Duplessis

Person

Somerville, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Isoindolinone derivatives as selective allosteric inhibitors of Egf...
- Patent number 12,209,091
- Issue date Jan 28, 2025
- HOFFMANN-LA ROCHE INC.
- Martin Duplessis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N/O-linked degrons and degronimers for protein degradation
- Patent number 12,180,225
- Issue date Dec 31, 2024
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- G07 - CHECKING-DEVICES
Information Patent Grant
Substituted piperidine Degronimers for Target Protein degradation
- Patent number 12,048,747
- Issue date Jul 30, 2024
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds
- Patent number 11,708,354
- Issue date Jul 25, 2023
- HOFFMANN-LA ROCHE INC.
- Martin Duplessis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoindolinone and indazole compounds for the degradation of EGFR
- Patent number 11,673,902
- Issue date Jun 13, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N/O-linked Degrons and Degronimers for protein degradation
- Patent number 11,459,335
- Issue date Oct 4, 2022
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted isoindole allosteric EGFR inhibitors
- Patent number 11,117,890
- Issue date Sep 14, 2021
- Hoffman-La Roche Inc.
- Georg Jaeschke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds
- Patent number 10,882,848
- Issue date Jan 5, 2021
- Hoffmann-La Roche, Inc.
- Martin Duplessis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
LSD1 inhibitors and uses thereof
- Patent number 10,526,287
- Issue date Jan 7, 2020
- Constellation Pharmaceuticals, Inc.
- Brian K. Albrecht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic compounds and uses thereof
- Patent number 10,358,437
- Issue date Jul 23, 2019
- Genentech, Inc.
- Brian K. Albrecht
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds and uses thereof
- Patent number 10,316,023
- Issue date Jun 11, 2019
- Genentech, Inc.
- Brian K. Albrecht
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds and uses thereof
- Patent number 10,308,614
- Issue date Jun 4, 2019
- Genentech, Inc.
- Brian K. Albrecht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic compounds and uses thereof
- Patent number 10,301,253
- Issue date May 28, 2019
- Genentech, Inc.
- Brian K. Albrecht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic compounds and uses thereof
- Patent number 10,239,861
- Issue date Mar 26, 2019
- Genetech, Inc.
- Brian K. Albrecht
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds and uses thereof
- Patent number 10,202,378
- Issue date Feb 12, 2019
- Genentech, Inc.
- Marc Adler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds and uses thereof
- Patent number 10,155,764
- Issue date Dec 18, 2018
- Genentech, Inc.
- Brian K. Albrecht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulators of methyl modifying enzymes, compositions and uses thereof
- Patent number 10,016,405
- Issue date Jul 10, 2018
- Constellation Pharmaceuticals, Inc.
- Brian K. Albrecht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulators of methyl modifying enzymes, compositions and uses thereof
- Patent number 9,980,952
- Issue date May 29, 2018
- Constellation Pharmaceuticals, Inc.
- Brian K. Albrecht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Indole derivatives as modulators of methyl modifying enzymes, compo...
- Patent number 9,969,716
- Issue date May 15, 2018
- Constellation Pharmaceuticals, Inc.
- Brian K. Albrecht
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of methyl modifying enzymes, compositions and uses thereof
- Patent number 9,371,331
- Issue date Jun 21, 2016
- Constellation Pharmaceuticals, Inc.
- Brian K. Albrecht
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of cytomegalovirus
- Patent number 9,334,249
- Issue date May 10, 2016
- Boehringer Ingelheim International GmbH
- Lee Fader
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of methyl modifying enzymes, compositions and uses thereof
- Patent number 9,085,583
- Issue date Jul 21, 2015
- Constellation Pharmaceuticals, Inc.
- Brian K. Albrecht
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Protein Tyrosine Phosphatase Degraders and Methods of Use Thereof
- Publication number 20240383886
- Publication date Nov 21, 2024
- Calico Life Sciences LLC
- Gesine Kerstin Veits
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF
- Publication number 20240199581
- Publication date Jun 20, 2024
- C4 Therapeutics, Inc.
- Christopher G. Nasveshuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EGFR Degraders to Treat Cancer Metastasis to the Brain or CNS
- Publication number 20240158418
- Publication date May 16, 2024
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR
- Publication number 20240076300
- Publication date Mar 7, 2024
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC HETEROBIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF TARGETED...
- Publication number 20230372496
- Publication date Nov 23, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N/O-Linked Degrons and Degronimers for Protein Degradation
- Publication number 20230279023
- Publication date Sep 7, 2023
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- G07 - CHECKING-DEVICES
Information Patent Application
BRAF DEGRADERS
- Publication number 20230145336
- Publication date May 11, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR
- Publication number 20230110648
- Publication date Apr 13, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL COMPOUNDS FOR THE TREATMENT OF CANCER
- Publication number 20230024096
- Publication date Jan 26, 2023
- HOFFMANN-LA ROCHE INC.
- Martin DUPLESSIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL COMPOUNDS
- Publication number 20230002367
- Publication date Jan 5, 2023
- HOFFMANN-LA ROCHE INC.
- Delphine GAUFRETEAU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PIPERIDINE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
- Publication number 20220313827
- Publication date Oct 6, 2022
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS
- Publication number 20210079005
- Publication date Mar 18, 2021
- HOFFMANN-LA ROCHE INC.
- Martin Duplessis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-BENZOPYRAZINYL-N-HETEROARYL-2-PHENYL-ACETAMIDE COMPOUNDS
- Publication number 20210070739
- Publication date Mar 11, 2021
- HOFFMANN-LA ROCHE INC.
- Martin Duplessis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL MOLECULES THAT DEGRADE EGFR
- Publication number 20200361930
- Publication date Nov 19, 2020
- HOFFMANN-LA ROCHE INC.
- Martin Duplessis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIFUNCTIONAL INHIBITORS WITH EGFR HAVING A E3 UBIQUITIN LIGASE MOIETY
- Publication number 20200308171
- Publication date Oct 1, 2020
- HOFFMANN-LA ROCHE INC.
- Georg Jaeschke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N/O-LINKED DEGRONS AND DEGRONIMERS FOR PROTEIN DEGRADATION
- Publication number 20200140456
- Publication date May 7, 2020
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS
- Publication number 20200102299
- Publication date Apr 2, 2020
- HOFFMANN-LA ROCHE INC.
- Georg Jaeschke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-BENZOPYRAZINYL-N-HETEROARYL-2-PHENYL-ACETAMIDE COMPOUNDS
- Publication number 20190308955
- Publication date Oct 10, 2019
- HOFFMANN-LA ROCHE INC.
- Martin Duplessis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF
- Publication number 20190125737
- Publication date May 2, 2019
- CONSTELLATION PHARMACEUTICALS, INC.
- Brian K. Albrecht
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMINE-LINKED C3-GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
- Publication number 20190076539
- Publication date Mar 14, 2019
- C4 Theraprutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LSD1 INHIBITORS AND USES THEREOF
- Publication number 20180290976
- Publication date Oct 11, 2018
- CONSTELLATION PHARMACEUTICALS, INC.
- Brian K. Albrecht
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC COMPOUNDS AND USES THEREOF
- Publication number 20180086720
- Publication date Mar 29, 2018
- Genentech, Inc.
- Brian K. Albrecht
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC COMPOUNDS AND USES THEREOF
- Publication number 20180037566
- Publication date Feb 8, 2018
- Genentech, Inc.
- Brian K. Albrecht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC COMPOUNDS AND USES THEREOF
- Publication number 20180009805
- Publication date Jan 11, 2018
- Genentech, Inc.
- Marc Adler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC COMPOUNDS AND USES THEREOF
- Publication number 20180009735
- Publication date Jan 11, 2018
- Genentech, Inc.
- Brian K. Albrecht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC COMPOUNDS AND USES THEREOF
- Publication number 20170334883
- Publication date Nov 23, 2017
- Genentech, Inc.
- Brian K. Albrecht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF
- Publication number 20170312262
- Publication date Nov 2, 2017
- CONSTELLATION PHARMACEUTICALS, INC.
- Brian K. Albrecht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC COMPOUNDS AND USES THEREOF
- Publication number 20170275289
- Publication date Sep 28, 2017
- Genentech, Inc.
- Brian K. Albrecht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF
- Publication number 20170056388
- Publication date Mar 2, 2017
- CONSTELLATION PHARMACEUTICALS, INC.
- Brian K. Albrecht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF
- Publication number 20160333016
- Publication date Nov 17, 2016
- CONSTELLATION PHARMACEUTICALS, INC.
- Brian K. Albrecht
- C07 - ORGANIC CHEMISTRY

Martin Duplessis

Person

Patents Grantslast 30 patents

Isoindolinone derivatives as selective allosteric inhibitors of Egf...

N/O-linked degrons and degronimers for protein degradation

Substituted piperidine Degronimers for Target Protein degradation

2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds

Isoindolinone and indazole compounds for the degradation of EGFR

N/O-linked Degrons and Degronimers for protein degradation

Substituted isoindole allosteric EGFR inhibitors

2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds

LSD1 inhibitors and uses thereof

Therapeutic compounds and uses thereof

Therapeutic compounds and uses thereof

Therapeutic compounds and uses thereof

Therapeutic compounds and uses thereof

Therapeutic compounds and uses thereof

Therapeutic compounds and uses thereof

Therapeutic compounds and uses thereof

Modulators of methyl modifying enzymes, compositions and uses thereof

Modulators of methyl modifying enzymes, compositions and uses thereof

Indole derivatives as modulators of methyl modifying enzymes, compo...

Modulators of methyl modifying enzymes, compositions and uses thereof

Inhibitors of cytomegalovirus

Modulators of methyl modifying enzymes, compositions and uses thereof

Patents Applicationslast 30 patents

Protein Tyrosine Phosphatase Degraders and Methods of Use Thereof

THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF

EGFR Degraders to Treat Cancer Metastasis to the Brain or CNS

ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR

TRICYCLIC HETEROBIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF TARGETED...

N/O-Linked Degrons and Degronimers for Protein Degradation

BRAF DEGRADERS

ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR

BIFUNCTIONAL COMPOUNDS FOR THE TREATMENT OF CANCER

BIFUNCTIONAL COMPOUNDS

SUBSTITUTED PIPERIDINE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

COMPOUNDS

2-BENZOPYRAZINYL-N-HETEROARYL-2-PHENYL-ACETAMIDE COMPOUNDS

BIFUNCTIONAL MOLECULES THAT DEGRADE EGFR

BIFUNCTIONAL INHIBITORS WITH EGFR HAVING A E3 UBIQUITIN LIGASE MOIETY

N/O-LINKED DEGRONS AND DEGRONIMERS FOR PROTEIN DEGRADATION

COMPOUNDS

2-BENZOPYRAZINYL-N-HETEROARYL-2-PHENYL-ACETAMIDE COMPOUNDS

MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF

AMINE-LINKED C3-GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

LSD1 INHIBITORS AND USES THEREOF

THERAPEUTIC COMPOUNDS AND USES THEREOF

THERAPEUTIC COMPOUNDS AND USES THEREOF

THERAPEUTIC COMPOUNDS AND USES THEREOF

THERAPEUTIC COMPOUNDS AND USES THEREOF

THERAPEUTIC COMPOUNDS AND USES THEREOF

MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF

THERAPEUTIC COMPOUNDS AND USES THEREOF

MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF

MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF